Oral Posters II (OP – 08) Transplantation II
	Moderators: Ernesto Molmenti, MD, Tucson, AZ and Ken Chavin, MD, Charleston, SC
	Abstract Numbers 168 – 177
	168.) Budd-Chiari syndrome report of 3 unique cases and review of the literature.
	Juan M Palma-vargas, MD, Jorge A Ortiz, MD, Helen L Goldberg, MD, Kenneth Lazarus, MD, Francis Wright, MD, Preston Foster, MD, Texas Transplant institute, San Antonio, TX.
	169.) Laparoscopic Incisional Hernia Repair After Liver Transplantation
	Kristin L Mekeel, MD, Kunam S. Reddy, MD, Adyr H. Moss, MD, David C. Mulligan, MD, Kristi L. Harold, MD, Mayo Clinic, Phoenix, AZ.
	170.) Changing Contraindications to Liver Transplantation with Improved Survival: Obesity, Age >65 and Malignancy
	Lynt B Johnson, MD, MBA, Kirti Shetty, MD, Amy D Lu, Georgetown Univ Hospital, Washington, DC.
	171.) Will Liver Transplant for Hepatocellular Cancer using the UCSF criteria help?
	Linda L Wong, MD, University of Hawaii School of Medicine, Honolulu, HI.
	172.) Middle hepatic vein of the recipient as drainage for anterior sector veins (Segments V-VIII) in adult-to-adult Living Donor Liver Transplantation. (LDLT)
	Manuel I Rodriguez-davalos, Juan Pablo Rocca, MD, Michael Marvin, MD, Patricia A Sheiner, MD, Marcelo E Facciuto, MD, New York Medical College, Hawthorne, NY; New York Medical College, Tarrytown, NY.
	173.) Intraoperative Placement Of An Expandable Metallic Stent For A Portal Vein Trombosis After Living Donor Liver Transplantation
	Diego Fernández, MD, Martín Palavecino, MD, Juan Salceda, MD, Juan Mattera, MD, Juan Pekolj, MD, Miguel Ciardullo, MD, Eduardo De Santibañes, MD, PhD, Hospital Italiano, Buenos Aires, Argentina.
	174.) Reassessing the impact of perioperative blood transfusions on outcomes of liver transplantation
	Markus Selzner, MD, Huang Zhang, MD, Nazia Selzner, MD, PhD, Paul Greig, MD, Mark Cattral, MD, David Grant, MD, Stuart Mccluskey, MD, Ian Mcgilvray, MD, PhD, Toronto General Hospital, Toronto, ON, Canada.
	175.) Choledochoduodenostomy Offers An Alternative Biliary Reconstruction To Choledochojejunostomy In Liver Transplantation
	William Bennet, MD, PhD, Michael Zimmermann, MD, Michael Wachs, MD, Tom Bak, MD, Igal Kam, MD, University of Colorado Health and Science Center, Denver, CO.
	176.) Outcome of Biliary Stricture after right Living Donor Liver Transplant
	A. Gangemi, MD, U. Bareato, MD, A. C. Owens, MD, J. Bui, MD, D. West, MD, M. Porubsky, MD, J. Oberholzer, MD, Enrico Benedetti, MD, G. Testa, MD, University of Illinois at Chicago, Chicago, IL; University of Chicago, Chicago, IL.
	177.) Predictors of Biliary Complications Following Living Donor Liver Transplantation.
	Timothy Michael Schmitt, MD, David Kashmer, MD, Timothy L Pruett, MD, University of Virginia, Charlottesville, VA.
	Oral Posters II (OP – 09) Biliary II: Benign and Pancreatitis
	Moderators: Ketan Sheth, MD, Boston, MA and Dan Deizel, MD, Chicago, IL
	Abstract Numbers 178 – 188
	178.) Longitudinal duodenotomy for excision of benign duodenal neoplasms
	B Dillard, J Hering, S Garrean, J Espat, UIC, Chicago, IL.
	179.) DIC-CT and intra-operative cholangiography for laparoscopic cholecystectomy
	Jun-ichi Tanaka, MD, PhD, Yoshio Deguchi, MD, PhD, Shin-ei Kudo, MD, PhD, Showa University Northern Yokohama Hospital, Yokohama, Japan.
	180.) Laparoscopic cholecystectomy in Progressive Systemic Sclerosis
	Nihar R Dash, Devendra Gupta, MD, Rajan Saxena, MS, AIIMS,New Delhi,India, New Delhi, India; SGPGIMs,Lucknow, Lucknow, India.
	181.) New Approaches for Bloodless Laparoscopic Cholecystectomy in the Cirrhotic Patient
	Geetha Jeyabalan, MD, T. Clark Gamblin, MD, Fady Balaa, MD, David A Geller, MD, UPMC Liver Cancer Center, University of Pittsburgh, Pittsburgh, PA.
	182.) Hemoconcentration As An Early Marker Of Severity In The Acute Biliary Pancreatitis
	Alberto Fersini, MD, Tiziano Pio Valentino, MD, Caterina Santacroce, MD, Nicola Tartaglia, MD, Antonio Ambrosi, MD, Vincenzo Neri, MD, University of Foggia, Foggia, Italy.
	183.) Refractomery Role for Diagnosis of Pathologic Process in Acute Pancreatitis
	Valentina Lisienko, Edvard Mikaelyan, Urals State Medical Academy, Ekaterinburg, Russian Federation.
	184.) Minimally Invasive Procedures For The Treatment Of Acute Pancreatic Pseudocysts
	Oscar Mazza, MD, Martín Palavecino, MD, Diego Fernández, MD, Ricardo Mentz, MD, Juan Pekolj, MD, Eduardo De Santibañes, Hospital Italiano, Buenos Aires, Argentina.
	185.) Adult Congenital Choledochal Cyst
	Ricardo Joaquin Mondragón-sánchez, MD, FRCP, Elizabeth Aguilar-alaniz 2003, MD, Alejandro Mondragón-sánchez 80, MD, Yisvanth Pérez-ponce 80, MD, issemym, Toluca, Mexico.
	186.) Treatment of benign biliary stenosis with temporary self-expandable metallic stent
	Maryléne Plasse, MD, Franck Vandenbroucke, Richard Létourneau, MD, Michel Dagenais, MD, Réal Lapointe, MD, André Roy, MD, Hopital Saint Luc-CHUM, Montréal, PQ, Canada.
	187.) Liver resection combined to bile duct repair after a bile duct injury during laparoscopic cholecystectomy
	Franck Vandenbroucke, Marylène Plasse, MD, Richard Létourneau, MD, Michel Dagenais, MD, André Roy, MD, Koen Vermeiren, MD, Réal Lapointe, MD, Hopital Saint Luc-CHUM, Montréal, PQ, Canada.
	188.) Parenchymal Sparing Central Hepatectomy for Hilar Stricture
	John Stauffer, MD, Marjorie Dougherty, PA-C, MPH, Denise Harnois, MD, Nguyen Justin, MD, Mayo Clinic, Jacksonville, FL.
	Oral Posters II (OP – 10) Basic Science II
	Moderators: Max Schmidt, MD, Indianpolis, IN and O. Joe Hines, MD, Los Angeles, CA
	Abstract Numbers 189 – 199
	189.) Age Increases Murine Resting Gallbladder Volume
	Abhishek Mathur, MD, Kyle Yancey, MD, Julia J. Walker, MS, Debao Lu, MD, Deborah A. Swartz-basile, PhD, Attila Nakeeb, MD, Henry A. Pitt, MD, Indiana University, Indianapolis, IN.
	190.) Development of a Reversible Surgical Model of Gallbladder Inflammation and Cholestasis.
	Carlos U Corvera, Jacob G Kirkland, Sanjay Kakar, Lygia Stewart, University of California, San Francisco, San Francisco, CA.
	191.) Challenges in primary steatotic hepatocyte isolation procedures.
	Justin D Ellett, John W Turner, MD, Eric Hall, Zachary P Evans, Kenneth D Chavin, MD, PhD, Medical University of South Carolina, Charleston, SC; Duke University, Durham, NC; CellzDirect, Inc., Pittsboro, NC.
	192.) Hepatic fibrosis induced by xenosera is featured by inconspicuous inflammation but robust ECM remodeling
	Gordon D Wu, Yao He, MD, PhD, Tomohito Sadahiro, MD, Jan Li, PhD, Hui Zhu, MD, PhD, Sangik Noh, MD, Andrew S Klein, MD, Cedars-Sinai Medical Center, Los Angeles, CA.
	193.) Liver Sinusoidal Endothelial Cells: Phenotypic Characterization by Electron Microscopy
	Luis J Garcia, MD, Olivier Rolin, Diego Avella, Eric Kimchi, MD, Kevin Staveley-o'carroll, MD, PhD, Penn State University, Hershey, PA.
	194.) Cellular heterogeneity of hepatic macrophages: Isolation and characterization of two subsets of ED2 (CD163) positive cells in the rat liver
	Gordon D Wu, MD, Yao He, MD, PhD, Tomohito Sadahiro, MD, PhD, Jan Li, PhD, Sang-ik Noh, MD, Hui Zhu, MD, PhD, Andrew S Klein, MD, Cedars-Sinai Medical Center, Los Angeles, CA.
	195.) Withdrawn
	Helge-Kleinhans, MD, Jussuf T Kaifi, MD, Felix Reinknecht, MD, Paulus Gabriel Schurr, MD, Bente Hansen, MS, Oliver Mann, MD, Jakob Robert Izbicki, PhD, Tim G Strate, MD, University Medical Center, Hamburg, Germany.
	196.) Leukocyte-endothelium interactions in acute pancreatitis after TNF-alpha modulation: an intravital microscopic study.
	Andre S Matheus, MD, PhD, Jose Jukemura, MD, Ana Maria M. Coelho, Paulina Sannomiya, PharmD, PhD, Naomi C. Nakagawa, Jose Eduardo M. Da Cunha, MD, PhD, Marcel C. C. Machado, MD, PhD, Dept. of Gastroenterology University of Sao Paulo, Sao Paulo, Brazil; Research Division-Heart Institute (InCor) University of Sao Paulo, Sao Paulo, Brazil.
	197.) The effect of ischaemic preconditioning in human liver sinusoidal endothelial cells following hypoxia-reoxygenation
	Dhanwant Gomez, Ann Graham, Nicholas Orsi, Uma Ekbote, Lance Burns, Shervanthi Homer-vanniasinkam, K.rajendra Prasad, Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom; University of Bradford, Bradford, United Kingdom; Leeds Institution of Molecular Biology, Leeds, United Kingdom; Department of Clinical Sciences, Sheffield, United Kingdom.
	198.) Ischemic Preconditioning and Intermittent Clamping Increase the Tolerance of Fatty Liver to Hepatic Ischemia-Reperfusion Injury in the Rat
	Reza F Saidi, MD, Jennifer Chang, MD, Steven Verb, MD, Steven Brooks, MD, I Nalbantoglu, MD, Volkan Adsay, MD, Michael J Jacobs, MD, Providence Hospital and Medical Centers, Southfield, MI; Detroit Medical Center, Detroit, MI.
	199.) Ischaemic preconditioning versus intermittent clamping on human liver sinusoidal endothelial cells: Effects on cytokines and growth factors
	Dhanwant Gomez, Ann Graham, Nicholas Orsi, Uma Ekbote, Lance Burns, Shervanthi Homer-vanniasinkam, K.rajendra Prasad, Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom; University of Bradford, Bradford, United Kingdom; Leeds Institution of Molecular Biology, Leeds, United Kingdom; University of Sheffield, Sheffield, United Kingdom.
	Oral Posters II (OP – 11) Pancreas II: Techniques, Neoplasm Potpourri
	Moderators: Craig Fischer, MD, Hoston, TX and Tom Howard, MD, Indianapolis, IN
	Abstract Numbers 200 – 211
	200.) A Single-Institution Retrospective Review Of Laparoscopic And Open Distal Pancreatectomies
	Beth Schrope, MD, PhD, John Allendorf, MD, Joseph Dinorcia, MD, Aliye Bill, None, Mary Digiorgi, MS, John Chabot, MD, Columbia University, New York, NY.
	201.) Open and Laparoscopic Spleen-Preserving, Splenic Vessel-Preserving Distal Pancreatectomy: Indications and Outcomes
	Matias Bruzoni, MD, Aaron R Sasson, MD, University of Nebraska Medical Center, Omaha, NE.
	202.) Cystic Pancreatic Neuroendocrine Tumors: A Rare Entity?
	Marshall S Baker, MD, MBA, John M Dewitt, MD, Pradermchai Kognkam, MD, Julia K Leblanc, MD, Harvey M Cramer, MD, Thomas J Howard, MD, C Max Schmidt, MD, PhD, Keith D Lillemoe, MD, Henry A Pitt, MD, Indiana University Medical Center, Indianapolis, IN.
	203.) Cystic Pancreatic Neoplams: An emerging problem.
	Kamran M. H. Karimi, MD, Irfan A. Rizvi, MD, Magesh Sundaram, MD, Harold J. Williams, MD, David W. Mcfadden, MD, WEST VIRGINIA UNIVERSITY, Morgantown, WV.
	204.) Current Diagnosis and Management of Solid Pseudopapillary Tumors of the Pancreas
	Gregory Watson, MD, Kevin Mcgrath, MD, Niraj Jani, MD, Kenneth Lee, MD, University of Pittsburgh, Pittsburgh, PA.
	205.) Incidence, Prevalence and Management of Intraductal Papillary Mucinous Neoplasm in Olmsted County, Minnesota, 1976-2005; A population study
	Kaye M Reid Lombardo, MD, Jennifer St. Sauver, PhD, Zhou Li, MS, William A Ahrens, MD, K. Krishnan Unni, Florencia G. Que, MD, Mayo Clinic, Rochester, MN.
	206.) Is Surgery necessary for The Treatment of Preoperative Diagnosed Ampulla of Vater Adenoma?
	Dong-sup Yoon, Joon Seong Park, MD, Kyung-sik Kim, MD, PhD, Jin Sub Choi, MD, Woo-jung Lee, MD, PhD, Hoon-sang Chi, MD, PhD, Byung-ro Kim, MD, PhD, Yonsei University Medical College, Seoul, Republic of Korea.
	207.) Somatostatinoma: A 20-year surgical experience.
	Gerard Abood, MD, Asghar Rizvi, None, Gerard Aranha, MD, Sherri Yong, MD, Margo Shoup, MD, Loyola University Medical Center, Maywood, IL.
	208.) Is There an Indication for Initial Conservative Management of Cystic Lesions of the Pancreas?
	Stephen R Grobmyer, MD, Steven N. Hochwald, MD, William G. Cance, MD, Stephen B. Vogel, MD, University of Florida, Gainesville, FL.
	209.) Frantz-Gruber Tumor-A Spectrum of Diseases and Surgical Treatment Options: Pancreaticoduodenectomy to Laparoscopic Distal Pancreatectomy
	Sean Garrean, MD, Justin Hering, MD, Barney Dillard, MD, Abdul Saied, MD, William Scott Helton, MD, Nocif Joseph Espat, MD, University of Illinois at Chicago, Chicago, IL.
	210.) Outcomes following aggressive surgery for malignant neuroendocrine tumours of the pancreas
	Glenn K Bonney, MBBS, Dhanwant Gomez, Caroline Verbeke, Sakhawat Rahman, Michael Mcmahon, Giles Toogood, K. Rajendra Prasad, J.peter Lodge, Krishna Menon, St James' University Hospital, Leeds, United Kingdom; St James' University Hospital, Leeds Ls9 7tf, United Kingdom.
	211.) Is Resection of Periampullary or Pancreatic Adenocarcinoma with Synchronous Hepatic Metastases Justified?
	Timothy M Pawlik, MD, MPH, Ana Gleisner, MD, Jordan Winter, MD, Michael Choti, MD, MBA, Richard Schulick, MD, John Cameron, MD, Johns Hopkins, Baltimore, MD.
	Oral Posters II (OP – 12) Pancreas III: Staging, Prognosis, Technical Issues
	Moderators: Attilla Nakeeb, MD, Indianpolis, IN and Stuart Marcus, MD, Bridgeport, CT
	Abstract Numbers 212 – 222
	212.) The Role Of Pancreaticoduodenectomy In The Treatment Of Complex Pancreatic Trauma
	Alexander R Karamarkovic, MD, PhD, University Center for Emergency Surgery, School of Medicine University of Belgrade, Belgrade, Serbia and Montenegro.
	213.) Anthropometric Assessment Of The “Staging Window” Prior To Pancreaticoduodenectomy.
	Kolitha S Goonetilleke, MBBS, Sorrel Burden, PhD, Ajith K Siriwardena, HPB Unit, Dept of Surgery, Manchester Royal Infirmary, Manchester, United Kingdom; Dept of Nutrition and Dietetics, Manchester Royal Infirmary, United Kingdom.
	214.) Characterization of Peri-operative Bleeding and Transfusion Utilization in a Modern Series of Pancreaticoduodenectomies
	Matthew J. Delano, MD, Steven N. Hochwald, MD, Chris A. Garces, MD, William G. Cance, MD, Stephen R. Grobmyer, MD, University of Florida, Gainesville, FL.
	215.) Modified Catell's Pancreatico-jejunostomy, buttressing and isolated bilio-pancreatic loop results in better outcomes following Pancreaticoduodenectomy
	Mohammad Abu-hilal, Hamilton-burke Wurbena, Glenn K Bonney, Krishna V Menon, St James' University Hospital, Leeds Ls9 7tf, United Kingdom.
	216.) Surgical Aspects Of Liver Arterialization After Pancreatectomy With Celiac Axis Resection For Locally Advanced Cancer Of The Pancreatic Body
	Emilio Vicente, MD, PhD, Yolanda Quijano, MD, PhD, Carmelo Loinaz, MD, PhD, Ramon D Conradi, MD, Fabiola Maches, MD, Luis Cordoba, MD, Elena Ayerbe, MD, Enrique Niembro, MD, Hospital Madrid-Monteprincipe, Boadilla Del Monte, Madrid, Spain.
	217.) Nodal sampling in periampullary cancer: Does it change your approach?
	Roozbeh Rassadi, MD, Dhiresh Rohan Jeyarajah, MD, Dallas Methodist Medical Center, Dallas, TX.
	218.) Lymph Node Ratio As A Predictive Factor In Pancreatic Adenocarcinoma
	Mohamed Alassas, J Wang, S Agrawal, J Parsons, K Stephen, J Wrozek, I Fung, J.f. Gibbs, Roswellpark cancer institute, Buffalo, NY; SUNY, Buffalo, NY.
	219.) Role of Preoperative 18-FDG-PET in Pancreatic Masses
	Marjorie K Dougherty, PA-C, MPH, Justin Nguyen, MD, Mayo Clinic Jacksonville, Jacksonville, FL.
	220.) Pancreatic resection for metastatic renal cell carcinoma to the pancreas.
	Kamran M. H. Karimi, MD, David W. Mcfadden, MD, WEST VIRGINIA UNIVERSITY, Morgantown, WV.
	221.) Unusual Early And Late Complications Of Pancreaticoduodenectomy: Recognition Is Paramount To Diagnosis
	Nicholas J Zyromski, MD, Attila Nakeeb, C. Max Schmidt, MD, PhD, Henry A Pitt, MD, Keith D Lillemoe, MD, Thomas J Howard, MD, Indiana University, Indianapolis, IN.
	222.) Life-threatening bleeding from duodenum due to pancreatic diseases.
	Yuki Sakuraoka, MD, Mitsugi Shimoda, MD, PhD, Masato Katoh, MD, PhD, Kyu Rokkaku, MD, PhD, Tokihiko Sawada, MD, PhD, Keiichi Kubota, MD, PhD, Dokkyo Univ, School of Med., Mibu, Tochigi, Japan.
	Oral Posters II (OP – 13) Liver IV: Metastatic Disease
	Moderators: Bill Hawkins, MD, St. Louis, MO and Rick Selby, MD, Los Angeles, CA
	Abstract Numbers 223 – 234
	223.) Surgical interventions for metastatic lesions to the liver: a national perspective
	James T Mcphee, MD, Joshua S Hill, MD, Zachary Hurwitz, MS, Giles F Whalen, MD, Mary E Sullivan, RN, Jennifer F Tseng, MD, University of Massachusetts Medical School, Worcester, MA.
	224.) Multimodal Treatment of Liver Metastasis from Gastrointestinal Stromal Tumours
	Osama M Damrah, Peter Sipos, Long Jiao, Nagy Habib, Hapreet Wasan, Ruben Canelo, Hammersmith Hospital, London, United Kingdom.
	225.) Hepatic resection for metastatic gastro-intestinal and pancreatic neuroendocrine tumours: Outcome and prognostic predictors
	Dhanwant Gomez, Karim Halazun, Ahmed Al-mukthar, Krishna V Menon, Giles J Toogood, J. Peter A Lodge, K. Rajendra Prasad, Leeds Teaching Hospitals NHS Trust, Leeds, Ls9 7tf, United Kingdom.
	226.) Partial hepatectomy for hepatic neuroendocrine malignancy: who benefits?
	Clifford S Cho, MD, Daniel M Labow, MD, Jinru Shia, MD, David S. Klimstra, MD, Mithat Gonen, PhD, William R. Jarnagin, MD, Michael I. D'angelica, MD, Leslie H. Blumgart, MD, Ronald P. Dematteo, MD, University of Wisconsin School of Medicine and Public Health, Madison, WI; Memorial Sloan-Kettering Cancer Center, New York, NY.
	227.) Simultaneous Resection Of Colorectal Tumors And Liver Metastases
	Juan Francisco Guerra Castro, MD, Enrique Norero, MD, Jorge Martínez, MD, George Pinedo, MD, Michel Butte, MD, Luis Ibañez, MD, Nicolás Jarufe, MD, Universidad Católica de Chile, Santiago De Chile, Chile.
	228.) Survival after resection of hepatic and pulmonary colorectal metastases
	Srinevas K Reddy, Andrew S. Barbas, MD, Thomas A. D'amico, MD, David H. Harpole Jr., MD, William R. Burfeind Jr., MD, Bryan M. Clary, MD, Duke University Medical Center, Durham, NC.
	229.) Outcomes after hepatic resection in the patients with colorectal cancer liver metastases: a retrospective comparison with non-resection cases
	Hyung-chul Kim, MD, PhD, Jong Woo Joo, MD, Chun Jun Cho, MD, Nam Kyu Choi, Hee Jae Lee, SoonChunHyang University Hospital, Bucheon,gyeonggi Do, Republic Of Korea, Republic of Korea; Ansan Jungang WAM Hospital, Ansan,gyeonggi Do, Republic Of Korea, Republic of Korea.
	230.) Prognostic factors in Hepatic Resections for the Colorectal cancer metastases
	Alexander R Karamarkovic, MD, PhD, University Center for Emergency Surgery, Belgrade, Serbia and Montenegro.
	231.) Predictors of early disease recurrence following hepatic resection for colorectal cancer metastasis
	Hassan Z Malik, Dhanwant Gomez, Giles J Toogood, J. Peter A Lodge, K. Rajendra Prasad, Leeds Teaching Hospitals NHS Trust, Leeds, Ls9 7tf, United Kingdom.
	232.) The Pathology Of Liver Nodules After Neoadjuvant Chemotherapy Is Associated With Outcome For Colorectal Cancer Metastases.
	Gabriel Chan, MD, Mazen Hassanain, MBBS, Prosanto Chaudhury, MD, Tamara Znajda, MD, Ryan Coughlin, B.Sc., Peter Metrakos, MD, Royal Victoria Hospital, McGill University Health Centre, Montreal, PQ, Canada.
	233.) Withdrawn
	234.) Resection for colorectal and non-colorectal liver metastases. A comparative study
	Ricardo Joaquin Mondragon-sanchez 80, MD, PhD, Rodrigo Jasso-barranco 2006, MD, Elvira Gomez-gomez 2003, MD, Alejandro Mondragon-sanchez 80, MD, Ofelia Arias-arias 2005, MD, Brenda Elena Aguilar-alvarez 2005, MD, Alicia Ivette Lopez-estrada 2006, MD, issemym, Toluca, Mexico.